Stock Markets March 18, 2026

Morgan Stanley Boosts Heidelberg Materials as Carbon Concerns Ease

Brokerage lifts rating to overweight, arguing carbon pricing fears have exaggerated downside and setting a €219 target

By Maya Rios
Morgan Stanley Boosts Heidelberg Materials as Carbon Concerns Ease

Morgan Stanley raised its recommendation on Heidelberg Materials from underweight to overweight and set a price target of €219, saying the recent share weakness reflects overstated fears about carbon costs. The upgrade and supporting analysis, including a reverse discounted cash flow model and operational outlook, sent the stock higher and highlights the brokerage's view that carbon pricing has not been the dominant force behind European cement pricing.

Key Points

  • Morgan Stanley upgraded Heidelberg Materials from underweight to overweight and set a €219 price target, citing overstated carbon pricing concerns and implying about 30.4% upside from the recent close.
  • The brokerage's analysis argues carbon pricing has not been the primary driver of European cement pricing, noting that free allowances have covered most sector emissions and that EUAs and cement PPIs have not moved in lockstep.
  • Morgan Stanley's forecasts place FY26 and FY27 EBIT above consensus, driven by margin improvements from the Transformation Accelerator programme and bolt-on acquisitions in Europe and North America; valuation metrics include 7.4x FY26 EV/EBITDA and a 7.1% FY26 free cash flow yield.

Morgan Stanley upgraded Heidelberg Materials from "underweight" to "overweight" on Wednesday and established a price target of €219, arguing that the stock's decline from its 52-week high has been driven in part by misplaced concerns about carbon costs. The brokerage noted a roughly 30% fall from the 52-week peak of €241.80 and said the rating change helped push the shares up more than 4% following the research note.

Shares had closed at €168 on Tuesday, not far above their 52-week low of €133.90, after moving down alongside European carbon allowance prices since late January.

In its written analysis Morgan Stanley said: "We see limited evidence that carbon pricing is the primary driver of cement pricing in Europe." The note added that generous allocations of free allowances have covered almost all emissions from the cement sector in recent years, which the brokerage argued undermines a straightforward cost-push explanation for recent pricing behaviour in the industry.

The research team contrasted market moves in carbon EUAs and cement producer price indices to support that point. Between 2016 and 2020 carbon EUAs rose by more than 300 percent while cement producer price indices in major European markets increased by less than 10 percent. More recently, Morgan Stanley noted a 24 percent drop in EUA prices since 2023 that coincided with a 10 percent rise in German and French cement PPIs.

Applying a reverse discounted cash flow framework, Morgan Stanley used a weighted average cost of capital of 8.3 percent and a terminal growth rate of 2.5 percent. Under those assumptions the brokerage calculated the current share price implies only 1.2 percent organic revenue growth. With an assumed 2 percent normalised pricing environment, that equates to a volumes contraction of roughly 1 percent, the note said.

However, Morgan Stanley described that implied outlook as overly pessimistic in light of Heidelberg's recent performance. The brokerage pointed to the company having delivered a 1 percent revenue compound annual growth rate over the past three years, achieved while Europe experienced significant volume declines.

On the earnings front, Morgan Stanley's forecasts have FY26 and FY27 EBIT estimates that sit 3 percent and 5 percent above consensus, respectively. The brokerage attributed that outperformance to margin upside from Heidelberg's Transformation Accelerator cost programme and to additional bolt-on acquisitions across Europe and North America.

Valuation metrics cited in the note show the stock trading at an estimated 7.4 times FY26 EV/EBITDA and offering a 7.1 percent FY26 free cash flow yield. Net debt to EBITDA was reported at about 1.2 times.

From Tuesday's close the €219 price target implies about 30.4 percent upside. Morgan Stanley also noted the range of consensus price targets stretches from €140 to €300, with a mean of €236.40.

The brokerage outlined scenario-based outcomes. Its bear case values the stock at €127, which assumes revenues decline 4 percent versus the FY26 base and EBITDA margins revert to 2022 levels. The bull case arrives at €269, premised on roughly 7 percent revenue CAGR and a 15 percent compound annual growth rate in EBIT from 2024 to 2030.


Analyst-driven tools and screening

The report also referenced AI-driven stock screening used by a separate product offering to evaluate whether Heidelberg Materials is a recommended buy. That product applies over 100 financial metrics across thousands of companies to identify opportunities based on fundamentals, momentum, and valuation.

Investors responding to the Morgan Stanley upgrade will weigh the brokerage's assumptions on carbon allowance dynamics, cost savings from transformation initiatives, and the potential for incremental acquisitions when assessing the stock's outlook.

Risks

  • Carbon market volatility remains a potential uncertainty for materials producers and related industrial sectors if allowance dynamics or policy change - this could influence costs and market perceptions.
  • Downside scenario where revenues fall and margins compress: Morgan Stanley's bear case values the stock at €127, driven by a 4% revenue decline and margin reversion to 2022 levels, which would affect sector cash flow and valuation metrics.
  • Execution and acquisition risk tied to the company's Transformation Accelerator cost programme and bolt-on transactions in Europe and North America; failure to realize expected margin gains would impact earnings and investor returns.

More from Stock Markets

Tadawul Advances as Media, Energy and Real Estate Stocks Lead Gains Mar 18, 2026 UBS Sees Wide Range for Global Equities; Extended Middle East Conflict Could Drive 30% Drop Mar 18, 2026 U.S. Futures Rise Ahead of Fed Decision; Lululemon, Duolingo Among Premarket Movers Mar 18, 2026 FDA Clears J&J's First Oral Psoriasis Treatment, Opening New Competitive Front in Immunology Mar 18, 2026 BMW Seeks to Stabilise China Position with New 'Neue Klasse' i3 Launch Mar 18, 2026